TreeWAS – Variant ID: rs6914079

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K83 Other diseases of biliary tract	0.559	0.441	0.000
K83.0 Cholangitis	0.552	0.448	0.000
K86 Other diseases of pancreas	0.549	0.451	0.000
K83.1 Obstruction of bile duct	0.546	0.454	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.546	0.454	0.000
K86.8 Other specified diseases of pancreas	0.542	0.458	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.509	0.491	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.509	0.491	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.507	0.493	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.500	0.500	0.000
K86.9 Disease of pancreas, unspecified	0.495	0.505	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.481	0.519	0.000
K86.1 Other chronic pancreatitis	0.480	0.520	0.000
K82 Other diseases of gallbladder	0.478	0.522	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.472	0.528	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.458	0.542	0.000
K82.4 Cholesterolosis of gallbladder	0.446	0.554	0.000
K83.5 Biliary cyst	0.444	0.556	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.443	0.557	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.438	0.562	0.000
K86.2 Cyst of pancreas	0.429	0.571	0.000
T42.4 Benzodiazepines	0.422	0.578	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.420	0.580	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.419	0.581	0.000
K83.9 Disease of biliary tract, unspecified	0.412	0.588	0.000
K85 Acute pancreatitis	0.411	0.589	0.000
K83.3 Fistula of bile duct	0.410	0.590	0.000
K80 Cholelithiasis	0.402	0.598	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.402	0.598	0.000
K83.2 Perforation of bile duct	0.398	0.602	0.000
T45.2 Vitamins, not elsewhere classified	0.396	0.604	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.391	0.609	0.000
T43.6 Psychostimulants with abuse potential	0.389	0.611	0.000
T50.8 Diagnostic agents	0.388	0.612	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.388	0.612	0.000
T50.4 Drugs affecting uric acid metabolism	0.388	0.612	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.387	0.613	0.000
K80.4 Calculus of bile duct with cholecystitis	0.387	0.613	0.000
K82.0 Obstruction of gallbladder	0.386	0.614	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.384	0.616	0.000
T46.1 Calcium-channel blockers	0.384	0.616	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.383	0.617	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.378	0.622	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.377	0.623	0.000
T43.2 Other and unspecified antidepressants	0.377	0.623	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.375	0.625	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.374	0.626	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.373	0.627	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.373	0.627	0.000
T50.1 Loop [high-ceiling] diuretics	0.372	0.628	0.000
T42.1 Iminostilbenes	0.369	0.631	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.367	0.633	0.000
K83.4 Spasm of sphincter of Oddi	0.366	0.634	0.000
T42.0 Hydantoin derivatives	0.365	0.635	0.000
T50.7 Analeptics and opioid receptor antagonists	0.365	0.635	0.000
T50.5 Appetite depressants	0.365	0.635	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.365	0.635	0.000
T50.0 Mineralocorticoids and their antagonists	0.365	0.635	0.000
K83.8 Other specified diseases of biliary tract	0.361	0.639	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.360	0.640	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.358	0.641	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.352	0.648	0.000
T45.0 Antiallergic and antiemetic drugs	0.351	0.648	0.000
K82.2 Perforation of gallbladder	0.348	0.652	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.347	0.653	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.347	0.653	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.345	0.655	0.000
T42.2 Succinimides and oxazolidinediones	0.345	0.655	0.000
K82.1 Hydrops of gallbladder	0.345	0.655	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.343	0.656	0.000
T45.5 Anticoagulants	0.341	0.659	0.000
T45.4 Iron and its compounds	0.340	0.660	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.339	0.661	0.000
T45.8 Other primarily systemic and haematological agents	0.339	0.661	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.339	0.661	0.000
T45.6 Fibrinolysis-affecting drugs	0.339	0.661	0.000
T45.3 Enzymes, not elsewhere classified	0.339	0.661	0.000
K86.3 Pseudocyst of pancreas	0.335	0.665	0.000
T42.3 Barbiturates	0.333	0.666	0.000
K85.1 Biliary acute pancreatitis	0.329	0.671	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.328	0.671	0.000
T46.7 Peripheral vasodilators	0.328	0.671	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.327	0.673	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.326	0.674	0.000
T43.9 Psychotropic drug, unspecified	0.325	0.675	0.000
T36 Poisoning by systemic antibiotics	0.324	0.676	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.321	0.679	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.320	0.680	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.315	0.685	0.000
K82.3 Fistula of gallbladder	0.314	0.686	0.000
K82.9 Disease of gallbladder, unspecified	0.306	0.694	0.000
K85.3 Drug-induced acute pancreatitis	0.304	0.696	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.304	0.696	0.000
T41.2 Other and unspecified general anaesthetics	0.301	0.699	0.000
K80.8 Other cholelithiasis	0.299	0.701	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.299	0.701	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.298	0.702	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.294	0.705	0.000
K85.8 Other acute pancreatitis	0.293	0.707	0.000
K85.2 Alcohol-induced acute pancreatitis	0.291	0.709	0.000
K80.3 Calculus of bile duct with cholangitis	0.288	0.712	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.287	0.713	0.000
T38.0 Glucocorticoids and synthetic analogues	0.286	0.714	0.000
K85.9 Acute pancreatitis, unspecified	0.285	0.715	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.284	0.716	0.000
K85.0 Idiopathic acute pancreatitis	0.281	0.719	0.000
K87.1 Disorders of pancreas in diseases classified elsewhere	0.281	0.719	0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.281	0.719	0.000
T41.5 Therapeutic gases	0.278	0.722	0.000
T41.4 Anaesthetic, unspecified	0.278	0.722	0.000
T41.3 Local anaesthetics	0.278	0.722	0.000
T41.1 Intravenous anaesthetics	0.278	0.722	0.000
T41.0 Inhaled anaesthetics	0.278	0.722	0.000
T38.1 Thyroid hormones and substitutes	0.278	0.722	0.000
K82.8 Other specified diseases of gallbladder	0.278	0.722	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.277	0.722	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.277	0.722	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.277	0.722	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.277	0.722	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.277	0.722	0.000
T44.0 Anticholinesterase agents	0.277	0.722	0.000
T38.5 Other oestrogens and progestogens	0.272	0.728	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.271	0.729	0.000
T38.9 Other and unspecified hormone antagonists	0.271	0.729	0.000
T38.7 Androgens and anabolic congeners	0.271	0.729	0.000
T38.4 Oral contraceptives	0.271	0.729	0.000
T38.2 Antithyroid drugs	0.271	0.729	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.258	0.742	0.000
T49.9 Topical agent, unspecified	0.258	0.742	0.000
T49.8 Other topical agents	0.258	0.742	0.000
T49.7 Dental drugs, topically applied	0.258	0.742	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.258	0.742	0.000
T49.5 Ophthalmological drugs and preparations	0.258	0.742	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.258	0.742	0.000
T49.3 Emollients, demulcents and protectants	0.258	0.742	0.000
T49.2 Local astringents and local detergents	0.258	0.742	0.000
T49.1 Antipruritics	0.258	0.742	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.257	0.743	0.000
K80.0 Calculus of gallbladder with acute cholecystitis	0.256	0.744	0.000
T47.2 Stimulant laxatives	0.254	0.745	0.000
T47.4 Other laxatives	0.254	0.746	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.253	0.747	0.000
T48.4 Expectorants	0.253	0.747	0.000
T48.3 Antitussives	0.253	0.747	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.253	0.747	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.253	0.747	0.000
T48.0 Oxytocic drugs	0.253	0.747	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.253	0.747	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.249	0.751	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.249	0.751	0.000
T47.7 Emetics	0.249	0.751	0.000
T47.5 Digestants	0.249	0.751	0.000
T47.3 Saline and osmotic laxatives	0.249	0.751	0.000
T47.0 Histamine H(2)-receptor antagonists	0.248	0.752	0.000
T36.8 Other systemic antibiotics	0.245	0.754	0.000
T47.6 Antidiarrhoeal drugs	0.237	0.763	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.234	0.765	0.000
T48.5 Anti-common-cold drugs	0.233	0.766	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.233	0.767	0.000
T36.9 Systemic antibiotic, unspecified	0.232	0.767	0.000
T36.7 Antifungal antibiotics, systemically used	0.232	0.767	0.000
T36.6 Rifamycins	0.232	0.767	0.000
T36.5 Aminoglycosides	0.232	0.767	0.000
T36.2 Chloramphenicol group	0.232	0.767	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.230	0.770	0.000
T37.5 Antiviral drugs	0.230	0.770	0.000
T37.4 Anthelminthics	0.230	0.770	0.000
T37.3 Other antiprotozoal drugs	0.230	0.770	0.000
T37.1 Antimycobacterial drugs	0.230	0.770	0.000
T37.0 Sulphonamides	0.230	0.770	0.000
T40.2 Other opioids	0.228	0.772	0.000
T36.3 Macrolides	0.228	0.772	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.224	0.776	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.215	0.785	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.215	0.785	0.000
T40.8 Lysergide [LSD]	0.215	0.785	0.000
T40.7 Cannabis (derivatives)	0.215	0.785	0.000
T40.0 Opium	0.215	0.785	0.000
T36.4 Tetracyclines	0.215	0.785	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.214	0.786	0.000
T36.0 Penicillins	0.211	0.789	0.000
T40.3 Methadone	0.210	0.790	0.000
T40.5 Cocaine	0.208	0.792	0.000
T40.1 Heroin	0.207	0.792	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.207	0.793	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.205	0.794	0.000
T40.4 Other synthetic narcotics	0.205	0.795	0.000
T39.0 Salicylates	0.178	0.822	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.176	0.824	0.000
T40.6 Other and unspecified narcotics	0.170	0.830	0.000
T39.4 Antirheumatics, not elsewhere classified	0.167	0.833	0.000
T39.2 Pyrazolone derivatives	0.167	0.833	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.164	0.836	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.127	0.873	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.122	0.877	0.000
T39.1 4-Aminophenol derivatives	0.076	0.924	0.000
K81 Cholecystitis	0.045	0.954	0.001
K81.8 Other cholecystitis	0.034	0.965	0.001
O44.1 Placenta praevia with haemorrhage	0.000	0.976	0.024
O72.1 Other immediate postpartum haemorrhage	0.024	0.976	0.000
O72 Postpartum haemorrhage	0.023	0.977	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.022	0.978	0.000
O72.0 Third-stage haemorrhage	0.021	0.979	0.000
O44 Placenta praevia	0.000	0.982	0.018
O44.0 Placenta praevia specified as without haemorrhage	0.000	0.983	0.017
O72.3 Postpartum coagulation defects	0.016	0.984	0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.011	0.989	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.000	0.991	0.009
E21.0 Primary hyperparathyroidism	0.008	0.992	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.008	0.992	0.000
K81.0 Acute cholecystitis	0.007	0.993	0.001
K81.9 Cholecystitis, unspecified	0.005	0.994	0.001
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.994	0.006
U88 Agent resistant to multiple antibiotics	0.006	0.994	0.000
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)	0.006	0.994	0.000
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)	0.006	0.994	0.000
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)	0.006	0.994	0.000
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)	0.006	0.994	0.000
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)	0.006	0.994	0.000
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)	0.006	0.994	0.000
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)	0.006	0.994	0.000
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)	0.006	0.994	0.000
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)	0.006	0.994	0.000
M80 Osteoporosis with pathological fracture	0.006	0.994	0.000
G81.9 Hemiplegia, unspecified	0.000	0.994	0.006
M77.1 Lateral epicondylitis	0.000	0.995	0.005
M80.0 Postmenopausal osteoporosis with pathological fracture	0.005	0.995	0.000
J95.8 Other postprocedural respiratory disorders	0.005	0.995	0.000
M80.5 Idiopathic osteoporosis with pathological fracture	0.005	0.995	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.005	0.995	0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.005	0.995	0.000
K80.2 Calculus of gallbladder without cholecystitis	0.005	0.995	0.000
K92.0 Haematemesis	0.005	0.995	0.000
M80.8 Other osteoporosis with pathological fracture	0.004	0.995	0.000
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.004	0.996	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.004	0.996	0.000
M80.4 Drug-induced osteoporosis with pathological fracture	0.004	0.996	0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.004	0.996	0.000
M80.2 Osteoporosis of disuse with pathological fracture	0.004	0.996	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.004	0.996	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.004	0.996	0.000
M77.19 Lateral epicondylitis (Site unspecified)	0.000	0.996	0.004
M77.18 Lateral epicondylitis-Other	0.000	0.996	0.004
M77.17 Lateral epicondylitis-Ankle/Foot	0.000	0.996	0.004
M77.16 Lateral epicondylitis (Lower leg)	0.000	0.996	0.004
M77.15 Lateral epicondylitis (Pelvic region and thigh)	0.000	0.996	0.004
M77.14 Lateral epicondylitis-Hand	0.000	0.996	0.004
M77.11 Lateral epicondylitis-Shldr region	0.000	0.996	0.004
M77.10 Lateral epicondylitis (Multiple sites)	0.000	0.996	0.004
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.004	0.996	0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.004	0.996	0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.004	0.996	0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.004	0.996	0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.004	0.996	0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.004	0.996	0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.004	0.996	0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.004	0.996	0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.004	0.996	0.000
M80.88 Other osteoporosis with pathological fracture (Other)	0.004	0.996	0.000
M77.13 Lateral epicondylitis-Forearm	0.000	0.996	0.004
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)	0.004	0.996	0.000
M80.58 Idiopathic osteoporosis with pathological fracture (Other)	0.004	0.996	0.000
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)	0.004	0.996	0.000
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)	0.004	0.996	0.000
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)	0.004	0.996	0.000
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)	0.004	0.996	0.000
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)	0.004	0.996	0.000
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)	0.004	0.996	0.000
G81 Hemiplegia	0.000	0.996	0.004
E87.5 Hyperkalaemia	0.004	0.996	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.004	0.996	0.000
M80.89 Other osteoporosis with pathological fracture (Site unspecified)	0.003	0.996	0.000
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)	0.003	0.996	0.000
M80.86 Other osteoporosis with pathological fracture (Lower leg)	0.003	0.996	0.000
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.996	0.000
M80.84 Other osteoporosis with pathological fracture (Hand)	0.003	0.996	0.000
M80.83 Other osteoporosis with pathological fracture (Forearm)	0.003	0.996	0.000
M80.82 Other osteoporosis with pathological fracture (Upper arm)	0.003	0.996	0.000
M80.80 Other osteoporosis with pathological fracture (Multiple sites)	0.003	0.996	0.000
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.28 Osteoporosis of disuse with pathological fracture (Other)	0.003	0.997	0.000
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.24 Osteoporosis of disuse with pathological fracture (Hand)	0.003	0.997	0.000
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)	0.003	0.997	0.000
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)	0.003	0.997	0.000
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)	0.003	0.997	0.000
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)	0.003	0.997	0.000
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.36 Postsurgical malabsorption osteoporosis with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.35 Postsurgical malabsorption osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.34 Postsurgical malabsorption osteoporosis with pathological fracture (Hand)	0.003	0.997	0.000
M80.33 Postsurgical malabsorption osteoporosis with pathological fracture (Forearm)	0.003	0.997	0.000
M80.32 Postsurgical malabsorption osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.31 Postsurgical malabsorption osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
M80.30 Postsurgical malabsorption osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
M80.49 Drug-induced osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.48 Drug-induced osteoporosis with pathological fracture (Other)	0.003	0.997	0.000
M80.47 Drug-induced osteoporosis with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.46 Drug-induced osteoporosis with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.45 Drug-induced osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.44 Drug-induced osteoporosis with pathological fracture (Hand)	0.003	0.997	0.000
M80.43 Drug-induced osteoporosis with pathological fracture (Forearm)	0.003	0.997	0.000
M80.42 Drug-induced osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.41 Drug-induced osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
M80.40 Drug-induced osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
U80 Agent resistant to penicillin and related antibiotics	0.003	0.997	0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.003	0.997	0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.003	0.997	0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
U84 Resistance to other antimicrobial drugs	0.003	0.997	0.000
U83 Resistance to other antibiotics	0.003	0.997	0.000
U82 Resistance to betalactam antibiotics	0.003	0.997	0.000
U85 Resistance to antineoplastic drugs	0.003	0.997	0.000
R22.4 Localised swelling, mass and lump, lower limb	0.003	0.997	0.000
U89 Agent resistant to other and unspecified antibiotics	0.003	0.997	0.000
A49.0 Staphylococcal infection, unspecified	0.000	0.997	0.003
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.003	0.997	0.000
M80.81 Other osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
G81.1 Spastic hemiplegia	0.000	0.997	0.003
U80.0 Penicillin resistant agent	0.003	0.997	0.000
D59.1 Other autoimmune haemolytic anaemias	0.003	0.997	0.000
K81.1 Chronic cholecystitis	0.001	0.997	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.003	0.997	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
B07 Viral warts	0.000	0.997	0.003
M77 Other enthesopathies	0.000	0.997	0.003
Chapter XXII Codes for special purposes	0.003	0.997	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.003	0.997	0.000
M20.0 Deformity of finger(s)	0.000	0.997	0.003
C34.9 Bronchus or lung, unspecified	0.003	0.997	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.003	0.997	0.000
G81.0 Flaccid hemiplegia	0.000	0.997	0.003
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M77.4 Metatarsalgia	0.000	0.997	0.003
M24.13 Other articular cartilage disorders (Forearm)	0.000	0.997	0.003
F31.7 Bipolar affective disorder, currently in remission	0.003	0.997	0.000
F31 Bipolar affective disorder	0.003	0.997	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.003	0.997	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.000	0.997	0.003
H74.0 Tympanosclerosis	0.000	0.997	0.003
U81.0 Vancomycin resistant agent	0.003	0.997	0.000
M77.5 Other enthesopathy of foot	0.000	0.997	0.003
O75.0 Maternal distress during labour and delivery	0.003	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.003	0.997	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.002	0.997	0.000
U82.8 Resistance to other betalactam antibiotics	0.002	0.997	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.002	0.997	0.000
U82.1 Resistance to methicillin	0.002	0.997	0.000
U82.0 Resistance to penicillin	0.002	0.997	0.000
U83.9 Resistance to unspecified antibiotic	0.002	0.997	0.000
U83.8 Resistance to other single specified antibiotic	0.002	0.997	0.000
U83.7 Resistance to multiple antibiotics	0.002	0.997	0.000
U83.2 Resistance to quinolones	0.002	0.997	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.002	0.997	0.000
U83.0 Resistance to vancomycin	0.002	0.997	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.002	0.997	0.000
U84.8 Resistance to other specified antimicrobial drug	0.002	0.997	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.002	0.997	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.002	0.997	0.000
U84.2 Resistance to antiviral drug(s)	0.002	0.997	0.000
U84.1 Resistance to antifungal drug(s)	0.002	0.997	0.000
U84.0 Resistance to antiparasitic drug(s)	0.002	0.997	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.003	0.997	0.000
U89.9 Agent resistant to unspecified antibiotic	0.002	0.997	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.003	0.997	0.000
E21.4 Other specified disorders of parathyroid gland	0.003	0.997	0.000
U50 Level of care administered to neonates	0.002	0.997	0.000
U07 Emergency use of U07	0.002	0.997	0.000
U06 Emergency use of U06	0.002	0.997	0.000
U04 Severe acute respiratory syndrome [SARS]	0.002	0.997	0.000
U52 First in a series of a regular day/night admissions	0.002	0.997	0.000
D59 Acquired haemolytic anaemia	0.003	0.997	0.000
F99 Mental disorder, not otherwise specified	0.003	0.997	0.000
S69.9 Unspecified injury of wrist and hand	0.000	0.997	0.003
U89.8 Agent resistant to other single specified antibiotic	0.002	0.997	0.000
M77.57 Other enthesopathy of foot-Ankle/Foot	0.000	0.997	0.002
M77.0 Medial epicondylitis	0.000	0.997	0.002
R22.7 Localised swelling, mass and lump, multiple sites	0.002	0.997	0.000
M77.3 Calcaneal spur	0.000	0.997	0.002
H74.4 Polyp of middle ear	0.000	0.997	0.003
R22.2 Localised swelling, mass and lump, trunk	0.003	0.997	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.002	0.997	0.000
R21 Rash and other nonspecific skin eruption	0.003	0.997	0.000
M77.8 Other enthesopathies, not elsewhere classified	0.000	0.998	0.002
M77.2 Periarthritis of wrist	0.000	0.998	0.002
O75.8 Other specified complications of labour and delivery	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.002	0.998	0.000
F31.9 Bipolar affective disorder, unspecified	0.002	0.998	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.002	0.998	0.000
F43.1 Posttraumatic stress disorder	0.002	0.998	0.000
O00.1 Tubal pregnancy	0.000	0.998	0.002
M77.49 Metatarsalgia-Site unspec	0.000	0.998	0.002
M77.48 Metatarsalgia-Other	0.000	0.998	0.002
M77.46 Metatarsalgia-Lower Leg	0.000	0.998	0.002
M77.45 Metatarsalgia-Pelvic/Thigh	0.000	0.998	0.002
M77.44 Metatarsalgia-Hand	0.000	0.998	0.002
M77.43 Metatarsalgia-Forearm	0.000	0.998	0.002
M77.42 Metatarsalgia-Upper arm	0.000	0.998	0.002
M77.41 Metatarsalgia-Shldr region	0.000	0.998	0.002
M77.40 Metatarsalgia-Mult sites	0.000	0.998	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
X78.0 Home	0.002	0.998	0.000
O75 Other complications of labour and delivery, not elsewhere classified	0.002	0.998	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
U51 Admission status on psychiatric patients	0.002	0.998	0.000
J95.0 Tracheostomy malfunction	0.002	0.998	0.000
O67.9 Intrapartum haemorrhage, unspecified	0.002	0.998	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.002	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.002	0.998	0.000
F31.8 Other bipolar affective disorders	0.002	0.998	0.000
M77.59 Other enthesopathy of foot-Site unspec	0.000	0.998	0.002
M77.58 Other enthesopathy of foot-Other	0.000	0.998	0.002
M77.56 Other enthesopathy of foot-Lower Leg	0.000	0.998	0.002
M77.55 Other enthesopathy of foot-Pelvic/Thigh	0.000	0.998	0.002
M77.54 Other enthesopathy of foot-Hand	0.000	0.998	0.002
M77.53 Other enthesopathy of foot-Forearm	0.000	0.998	0.002
M77.52 Other enthesopathy of foot-Upper arm	0.000	0.998	0.002
M77.51 Other enthesopathy of foot-Shldr region	0.000	0.998	0.002
M77.50 Other enthesopathy of foot-Mult sites	0.000	0.998	0.002
D36.7 Other specified sites	0.002	0.998	0.000
D59.9 Acquired haemolytic anaemia, unspecified	0.002	0.998	0.000
D59.4 Other nonautoimmune haemolytic anaemias	0.002	0.998	0.000
J95.4 Mendelson's syndrome	0.002	0.998	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.002	0.998	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.002	0.998	0.000
D58 Other hereditary haemolytic anaemias	0.002	0.998	0.000
D58.9 Hereditary haemolytic anaemia, unspecified	0.002	0.998	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.002	0.998	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.998	0.002
J95.5 Postprocedural subglottic stenosis	0.002	0.998	0.000
R22.3 Localised swelling, mass and lump, upper limb	0.002	0.998	0.000
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.002	0.998	0.000
M77.02 Medial epicondylitis (Upper arm)	0.000	0.998	0.002
M77.37 Calcaneal spur-Ankle/Foot	0.000	0.998	0.002
G82.1 Spastic paraplegia	0.000	0.998	0.002
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
D59.8 Other acquired haemolytic anaemias	0.002	0.998	0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.002	0.998	0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.002	0.998	0.000
D59.3 Haemolytic-uraemic syndrome	0.002	0.998	0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.002	0.998	0.000
D59.0 Drug-induced autoimmune haemolytic anaemia	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.002	0.998	0.000
U06.9 Emergency use of U06.9	0.002	0.998	0.000
U06.8 Emergency use of U06.8	0.002	0.998	0.000
U06.7 Emergency use of U06.7	0.002	0.998	0.000
U06.6 Emergency use of U06.6	0.002	0.998	0.000
U06.5 Emergency use of U06.5	0.002	0.998	0.000
U06.4 Emergency use of U06.4	0.002	0.998	0.000
U06.3 Emergency use of U06.3	0.002	0.998	0.000
U06.2 Emergency use of U06.2	0.002	0.998	0.000
U06.1 Emergency use of U06.1	0.002	0.998	0.000
U06.0 Emergency use of U06.0	0.002	0.998	0.000
U07.9 Emergency use of U07.9	0.002	0.998	0.000
U07.8 Emergency use of U07.8	0.002	0.998	0.000
U07.7 Emergency use of U07.7	0.002	0.998	0.000
U07.6 Emergency use of U07.6	0.002	0.998	0.000
U07.5 Emergency use of U07.5	0.002	0.998	0.000
U07.4 Emergency use of U07.4	0.002	0.998	0.000
U07.3 Emergency use of U07.3	0.002	0.998	0.000
U07.2 Emergency use of U07.2	0.002	0.998	0.000
U07.1 Emergency use of U07.1	0.002	0.998	0.000
U07.0 Emergency use of U07.0	0.002	0.998	0.000
U50.9 Inquest Adjourned Death	0.002	0.998	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.002	0.998	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.002	0.998	0.000
U50.1 Level of care administered to neonates (Special Care)	0.002	0.998	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.002	0.998	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.998	0.002
M77.09 Medial epicondylitis (Site unspecified)	0.000	0.998	0.002
M77.08 Medial epicondylitis-Other	0.000	0.998	0.002
M77.07 Medial epicondylitis-Ankle/Foot	0.000	0.998	0.002
M77.06 Medial epicondylitis (Lower leg)	0.000	0.998	0.002
M77.05 Medial epicondylitis (Pelvic region and thigh)	0.000	0.998	0.002
M77.04 Medial epicondylitis-Hand	0.000	0.998	0.002
M77.03 Medial epicondylitis-Forearm	0.000	0.998	0.002
M77.01 Medial epicondylitis-Shldr region	0.000	0.998	0.002
M77.00 Medial epicondylitis (Multiple sites)	0.000	0.998	0.002
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.002	0.998	0.000
M77.39 Calcaneal spur-Site unspec	0.000	0.998	0.002
M77.38 Calcaneal spur-Other	0.000	0.998	0.002
M77.36 Calcaneal spur-Lower Leg	0.000	0.998	0.002
M77.35 Calcaneal spur-Pelvic/Thigh	0.000	0.998	0.002
M77.34 Calcaneal spur-Hand	0.000	0.998	0.002
M77.33 Calcaneal spur-Forearm	0.000	0.998	0.002
M77.32 Calcaneal spur-Upper arm	0.000	0.998	0.002
M77.31 Calcaneal spur-Shldr region	0.000	0.998	0.002
M77.30 Calcaneal spur-Mult sites	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations